JP2022504435A5 - - Google Patents
Info
- Publication number
- JP2022504435A5 JP2022504435A5 JP2021518962A JP2021518962A JP2022504435A5 JP 2022504435 A5 JP2022504435 A5 JP 2022504435A5 JP 2021518962 A JP2021518962 A JP 2021518962A JP 2021518962 A JP2021518962 A JP 2021518962A JP 2022504435 A5 JP2022504435 A5 JP 2022504435A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- interferon
- beta
- product according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862743449P | 2018-10-09 | 2018-10-09 | |
| US62/743,449 | 2018-10-09 | ||
| PCT/US2019/055167 WO2020076809A1 (en) | 2018-10-09 | 2019-10-08 | Combination of ibudilast and interferon-beta and methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022504435A JP2022504435A (ja) | 2022-01-13 |
| JP2022504435A5 true JP2022504435A5 (https=) | 2022-10-13 |
Family
ID=68343518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518962A Pending JP2022504435A (ja) | 2018-10-09 | 2019-10-08 | イブジラストとインターフェロン－ベータとの組み合わせ、およびそれを使用する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10946071B2 (https=) |
| EP (1) | EP3863628B1 (https=) |
| JP (1) | JP2022504435A (https=) |
| CN (1) | CN112770748A (https=) |
| CA (1) | CA3115269A1 (https=) |
| ES (1) | ES2973119T3 (https=) |
| WO (1) | WO2020076809A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12005049B2 (en) | 2021-07-26 | 2024-06-11 | Medicinova, Inc. | Methods of preventing cancer metastasis |
| US12042485B2 (en) | 2021-10-07 | 2024-07-23 | Medicinova, Inc. | Methods of minimizing cancer metastasis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395747B1 (en) | 1998-08-10 | 2002-05-28 | Sauro Sakoda | Remedies for multiple sclerosis |
| US20060093578A1 (en) * | 2004-11-04 | 2006-05-04 | Kyorin Pharmaceutical Co., Ltd. | Method and composition for treating multiple sclerosis |
| JP4954085B2 (ja) | 2004-12-06 | 2012-06-13 | メディシノバ， インコーポレイテッド | 神経障害性疼痛及びその関連する症状を治療するためのイブジラスト |
| WO2007135172A2 (en) * | 2006-05-24 | 2007-11-29 | Laboratoires Serono S.A. | Cladribine regimen for treating multiple sclerosis |
| US8138201B2 (en) | 2007-07-11 | 2012-03-20 | Medicinova, Inc. | Treatment of progressive neurodegenerative disease with ibudilast |
| EP2277515A1 (en) * | 2009-07-10 | 2011-01-26 | Sanofi-Aventis | Use of the combination of teriflunomide and interferon beta for treating multiple sclerosis |
| AU2011338647A1 (en) * | 2010-12-07 | 2013-07-04 | Teva Pharmaceutical Industries Ltd. | Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients |
| EP3502236B1 (en) * | 2011-02-18 | 2023-08-23 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
-
2019
- 2019-10-08 WO PCT/US2019/055167 patent/WO2020076809A1/en not_active Ceased
- 2019-10-08 JP JP2021518962A patent/JP2022504435A/ja active Pending
- 2019-10-08 ES ES19794366T patent/ES2973119T3/es active Active
- 2019-10-08 CN CN201980065787.0A patent/CN112770748A/zh active Pending
- 2019-10-08 EP EP19794366.5A patent/EP3863628B1/en active Active
- 2019-10-08 US US16/596,278 patent/US10946071B2/en active Active
- 2019-10-08 CA CA3115269A patent/CA3115269A1/en active Pending